(Q29620791)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

1 reference

0 references

1 reference

Gerlach JT

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

Diepolder HM

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

Jung MC

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

Gruener NH

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

Schraut WW

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

Zachoval R

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

Hoffmann R

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

Schirren CA

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

Santantonio T

9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

Pape GR

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

October 1999

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

volume

117

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

page(s)

933-41

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

30 April 2017

issue

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10500077

Epidemiology of hepatitis C

30 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Hepatitis C: the clinical spectrum of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Effect of immune globulin on the prevention of experimental hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Number of interleukin-4- and interferon-γ-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Long-lasting memory T cell responses following self-limited acute hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Hepatitis B virus immunopathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

7 January 2021

Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

7 January 2021

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

7 January 2021

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

7 January 2021

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

7 January 2021

Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970353-7

7 January 2021